Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
AbbVie
(NY:
ABBV
)
188.86
+0.29 (+0.15%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AbbVie
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
68
69
Next >
Healthcare Is Lagging But Biotech Offers Good Potential For Value And Trading
March 06, 2023
Over the past week, the market had a nice uptick making it harder for defensive sectors like healthcare to get traction up only 0.51% and down almost 5% YTD.
Via
Talk Markets
2 Top Dividend Kings to Buy for the Long Haul
March 04, 2023
These aren't just dividend plays, either.
Via
The Motley Fool
2 High-Yield Dividend Stocks to Buy in March
March 04, 2023
Putting some shares of these stocks in your portfolio now could lead to heaps of passive income in your retirement years.
Via
The Motley Fool
Could This Humira Biosimilar Be a Winner for Amgen?
March 03, 2023
This Humira biosimilar just launched in the U.S. several weeks ago.
Via
The Motley Fool
Intel Slashed Its Dividend, But These 3 Yields Are Likely to Continue Rising
March 02, 2023
These are dividend stocks you won't have to worry about.
Via
The Motley Fool
These 2 Dividend Stocks Could Be a Great Addition to Your Income Portfolio
March 02, 2023
They'll generate cash now, and even more cash in the future.
Via
The Motley Fool
8 Analysts Have This to Say About AbbVie
March 01, 2023
Via
Benzinga
What Does AbbVie's Debt Look Like?
February 28, 2023
Over the past three months, shares of AbbVie Inc. (NYSE:ABBV) moved lower by 6.39%. Before having a look at the importance of debt, let's look at how much debt AbbVie has.
Via
Benzinga
3 Stocks to Buy Right Now That Are Cash Cows
February 25, 2023
If cash is king, these three stocks should wear crowns.
Via
The Motley Fool
Wall Street Sees 23% Upside In Revance, Maker Of Botox Competitor
March 02, 2023
Revance Therapeutics gapped up 54.34% on January 9, and built upon those gains in February. The company reported its first revenue for Botox competitor Daxxify.
Via
MarketBeat
AbbVie Can Write Diversified Growth Story Without Humira, Rest Of The Business Has Strength, Analyst Says
March 01, 2023
Via
Benzinga
3 Top Defensive Stocks to Own for a Focus on Quality
March 01, 2023
For those looking to invest in quality, look no further than these three top defensive stocks as ways to combat uncertainty in this market.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023
March 01, 2023
Via
Benzinga
3 Value Stocks You'll Regret Not Buying on the Dip
March 01, 2023
These three undervalued healthcare stocks are solid picks for patient investors.
Via
The Motley Fool
Get a Dividend Every Month With These 3 Healthcare Stocks
March 01, 2023
With a little planning, you can receive a dependable dividend payout every month.
Via
The Motley Fool
Peering Into AbbVie's Recent Short Interest
February 28, 2023
AbbVie's (NYSE:ABBV) short percent of float has risen 13.79% since its last report. The company recently reported that it has 11.71 million shares sold short, which is 0.66% of all regular shares that...
Via
Benzinga
3 High-Yield Dividend Stocks to Buy and Hold Forever
February 27, 2023
These three high-yield dividend stocks should provide stable returns and continue to grow quickly, making them solid investments.
Via
InvestorPlace
7 Mega-Cap Stocks to Buy for the Long Haul
February 26, 2023
If you’re looking for a stock you can buy and hold for a long time, then these mega-cap stocks to by fit the bill.
Via
InvestorPlace
Recent Stock Purchase/Sale February 2023
February 26, 2023
I have been busy buying up some stock this month and was happy to put some fresh and recycled capital to work to try and recoup some of my lost dividend income courtesy of the numerous cuts bestowed...
Via
Talk Markets
The Ultimate Inflation Hedge: Dividends
February 24, 2023
Whatever the inflation rate that unfolds during the next 10-30 years, your annual expenses will be going up each year. In such an environment, a bond and cash portfolio will not see you through...
Via
Talk Markets
Infinity Pharmaceuticals Announce Merger Agreement With MEI Pharma, Share Plunge
February 23, 2023
Via
Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Healthcare Stocks Delivering High-Dividend Yields
February 23, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
7 Dividend Yield Monsters Poised to Soar
February 23, 2023
These high-yield dividend stocks are poised to soar as investors pile onto growing companies offering regular income.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023
February 22, 2023
Via
Benzinga
Want to Get to $1 Million by Retirement? Here's How Much You Should Invest Today.
February 22, 2023
If you want to be a millionaire more quickly, you can always invest more along the way.
Via
The Motley Fool
Analyst Confidence in Eli Lilly Boosted by Product Pipeline
February 22, 2023
Eli Lilly has long been a reliable stock, but with the company's impressive product pipeline, the stock could hold significant potential in the near term.
Via
MarketBeat
Want More Reliable Dividend Income? Buy This Dividend King.
February 22, 2023
This big pharma company possesses a deep drug portfolio and pipeline.
Via
The Motley Fool
This Recession-Proof Company Has a Best-in-Class Dividend
February 22, 2023
Pfizer's highly attractive valuation, rock-solid dividend program, and enormous yield put it at the top of its big pharma peer group.
Via
The Motley Fool
Johnson & Johnson: Taking The Bull By The Horns?
February 21, 2023
Johnson & Johnson is rushing toward a patent cliff but a new shelf offering registration suggests itis gearing up for acquisitions.
Via
MarketBeat
Topics
Intellectual Property
Regulatory Compliance
Exposures
Intellectual Property
Legal
Regulatory
3 Top Dividend Kings to Buy for the Long Haul
February 20, 2023
These companies have more than 150 years of dividend growth between them.
Via
The Motley Fool
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
68
69
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.